Emergence of community behaviors in the gut microbiota upon drug treatment

Cardiovascular and Metabolic Diseases Molecular Processes and Therapies [Topic 2]
DOI: 10.1101/2023.06.13.544832 Publication Date: 2023-06-14T16:05:10Z
ABSTRACT
Summary Pharmaceuticals can directly inhibit the growth of gut bacteria, but degree such interactions manifest in complex community settings is an open question. Here we compared effects 30 drugs on a 32-species synthetic with their each member isolation. While most individual drug–species remained same context, communal behaviors emerged 26% all tested cases. Cross-protection, during which drug-sensitive species became protected community, was 6-times more frequent than cross-sensitization, converse phenomenon. Cross-protection decreased and cross-sensitization increased at higher drug concentrations, suggesting that resilience microbial communities collapse when perturbations get stronger. By metabolically profiling drug-treated communities, showed both biotransformation bioaccumulation contribute mechanistically to protection. As proof-of-principle, molecularly dissected prominent case: expressing specific nitroreductases degraded niclosamide, thereby protecting themselves sensitive members.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....